Published in J Biol Chem on November 04, 2009
Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 2.96
Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. PLoS Pathog (2010) 1.19
Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate. J Biol Chem (2011) 1.19
The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis (2009) 1.12
Genetic analysis of the heparan modification network in Caenorhabditis elegans. J Biol Chem (2011) 1.05
Hepcidin antagonists for potential treatments of disorders with hepcidin excess. Front Pharmacol (2014) 1.04
Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development. Development (2012) 1.03
Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J Biol Chem (2010) 1.02
Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice. Blood (2012) 0.97
Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. PLoS Pathog (2011) 0.96
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. J Clin Invest (2013) 0.95
Syndecan-1 is required to maintain intradermal fat and prevent cold stress. PLoS Genet (2014) 0.94
Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans. PLoS One (2010) 0.94
Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. Dev Biol (2011) 0.93
Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins. Hepatology (2010) 0.92
Insulin-dependent diabetes mellitus in mice does not alter liver heparan sulfate. J Biol Chem (2010) 0.91
Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice. PLoS One (2010) 0.90
Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice. Arterioscler Thromb Vasc Biol (2013) 0.90
Modifications of glycans: biological significance and therapeutic opportunities. ACS Chem Biol (2012) 0.90
The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans. Microsc Microanal (2012) 0.86
Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance. Hepatology (2011) 0.85
Meta-analysis identifies gene-by-environment interactions as demonstrated in a study of 4,965 mice. PLoS Genet (2014) 0.85
Human genetic disorders and knockout mice deficient in glycosaminoglycan. Biomed Res Int (2014) 0.85
Glucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks. Ann Hum Genet (2011) 0.83
Changes in expression of proteoglycan core proteins and heparan sulfate enzymes in the developing and adult murine aorta. J Cardiovasc Transl Res (2011) 0.81
Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects. PLoS One (2013) 0.79
2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection. J Biol Chem (2015) 0.78
Role of heparan sulfate proteoglycans in optic disc and stalk morphogenesis. Dev Dyn (2014) 0.77
Glycosaminoglycans and infection. Front Biosci (Landmark Ed) (2016) 0.77
Role of glycosaminoglycans in infectious disease. Methods Mol Biol (2015) 0.77
Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans. J Lipid Res (2015) 0.76
Genetic risk variants for metabolic traits in Arab populations. Sci Rep (2017) 0.75
The role of heparan sulphate in development: the ectodermal story. Int J Exp Pathol (2016) 0.75
Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med (1954) 68.67
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2001) 7.87
Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 6.94
Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis (1989) 5.88
Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). Anal Biochem (1981) 5.49
Molecular diversity of heparan sulfate. J Clin Invest (2001) 5.40
DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis (2000) 5.09
Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol (2006) 3.49
Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler Thromb Vasc Biol (2009) 2.99
Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. J Clin Invest (1999) 2.66
A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet (1999) 2.56
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest (2007) 2.53
Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev (1998) 2.51
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res (1999) 2.39
Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem (2004) 2.14
Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem (1993) 1.92
Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat Methods (2008) 1.84
Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem (2000) 1.76
Differential sulfations and epimerization define heparan sulfate specificity in nervous system development. Neuron (2004) 1.75
The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr Opin Lipidol (2004) 1.73
Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development (2005) 1.69
Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem Sci (2003) 1.67
Structural analysis of glycosaminoglycans in animals bearing mutations in sugarless, sulfateless, and tout-velu. Drosophila homologues of vertebrate genes encoding glycosaminoglycan biosynthetic enzymes. J Biol Chem (2000) 1.61
Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J Biol Chem (1992) 1.60
Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J Biol Chem (2005) 1.55
The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J Clin Invest (1997) 1.55
The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J Biol Chem (2001) 1.55
Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. Curr Opin Lipidol (1997) 1.53
An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation. J Biol Chem (1996) 1.52
Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling. J Cell Biol (2006) 1.44
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest (1998) 1.32
Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem (1994) 1.27
Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality. J Biol Chem (2007) 1.27
Biosynthesis of heparan sulfate. Coordination of polymer-modification reactions in a Chinese hamster ovary cell mutant defective in N-sulfotransferase. J Biol Chem (1991) 1.23
Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. Biochemistry (2001) 1.22
Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Biochemistry (2001) 1.21
Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J Biol Chem (1994) 1.20
Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin Chem (1986) 1.19
Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway. J Biol Chem (2003) 1.18
New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J Biol Chem (2001) 1.17
Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem (1997) 1.13
Perlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism. J Biol Chem (2000) 1.13
Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J Biol Chem (1994) 1.12
Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem (1996) 1.12
Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J Lipid Res (1995) 1.12
The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism. J Biol Chem (2003) 1.10
Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. J Biol Chem (2007) 1.07
Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. Curr Atheroscler Rep (2004) 1.05
Identification of the proteoglycan binding site in apolipoprotein B48. J Biol Chem (2002) 1.04
Redirecting the substrate specificity of heparan sulfate 2-O-sulfotransferase by structurally guided mutagenesis. Proc Natl Acad Sci U S A (2008) 1.01
Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler Thromb (1994) 0.99
Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins? Ann Med (2006) 0.99
Systemic inactivation of Hs6st1 in mice is associated with late postnatal mortality without major defects in organogenesis. Genesis (2008) 0.95
Biosynthesis of heparin. O-sulfation of D-glucuronic acid units. J Biol Chem (1990) 0.93
Effect of very low molecular weight heparin-derived oligosaccharides on lipoprotein lipase release in rabbits. Atherosclerosis (1986) 0.92
Binding of hepatic lipase to heparin. Identification of specific heparin-binding residues in two distinct positive charge clusters. J Lipid Res (2000) 0.90
Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. Biochemistry (1997) 0.89
Chylomicron remnant uptake is regulated by the expression and function of heparan sulfate proteoglycan in hepatocytes. J Lipid Res (1998) 0.88
The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans. J Biol Chem (1998) 0.87
Mapping the heparin-binding domain of human hepatic lipase. Biochem Biophys Res Commun (2006) 0.87
Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver. Hepatology (1996) 0.85
Interactions of lipoproteins with proteoglycans. Methods Mol Biol (2001) 0.84
Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase. J Biol Chem (2006) 0.83
Inhibition of apolipoprotein E-related neurotoxicity by glycosaminoglycans and their oligosaccharides. Biochemistry (2002) 0.83
Selective impairment of the synthesis of basic fibroblast growth factor binding domains of heparan sulphate in a COS cell mutant defective in N-sulphotransferase. Glycobiology (1993) 0.81
Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature (2007) 7.87
A myocardial lineage derives from Tbx18 epicardial cells. Nature (2008) 6.15
The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer (2005) 5.98
Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol (2005) 3.82
Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell (2004) 3.28
Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest (2011) 2.99
Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 2.96
miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol (2010) 2.87
Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe (2007) 2.64
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest (2007) 2.53
Notch signaling controls the balance of ciliated and secretory cell fates in developing airways. Development (2009) 2.33
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest (2002) 1.91
Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes. J Biol Chem (2005) 1.91
Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling. J Biol Chem (2008) 1.91
Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem (2004) 1.87
Mammalian hyaluronan synthases. IUBMB Life (2002) 1.85
Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development (2005) 1.84
Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat Methods (2008) 1.84
Demystifying heparan sulfate-protein interactions. Annu Rev Biochem (2014) 1.76
Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci U S A (2002) 1.76
Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex. J Biol Chem (2004) 1.73
Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. J Biol Chem (2008) 1.73
Caenorhabditis elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis. Nature (2003) 1.73
Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing. Am J Respir Crit Care Med (2006) 1.72
Inhibition of Tgf beta signaling by endogenous retinoic acid is essential for primary lung bud induction. Development (2007) 1.70
Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development (2005) 1.69
SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. J Biol Chem (2006) 1.65
A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem (2004) 1.60
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J Clin Invest (2009) 1.56
Symbol nomenclature for glycan representation. Proteomics (2009) 1.56
Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J Biol Chem (2009) 1.55
Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest (2008) 1.52
A caudorostral wave of RALDH2 conveys anteroposterior information to the cardiac field. Development (2003) 1.51
miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle (2010) 1.51
A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology (2005) 1.49
An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity. Blood (2013) 1.47
Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. Development (2006) 1.46
Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling. J Cell Biol (2006) 1.44
Sulfation pattern in glycosaminoglycan: does it have a code? Glycoconj J (2004) 1.43
Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses. Nat Chem Biol (2012) 1.43
Heparan sulfate fine structure and specificity of proteoglycan functions. Biochim Biophys Acta (2002) 1.42
Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS One (2010) 1.42
Resistance to a bacterial toxin is mediated by removal of a conserved glycosylation pathway required for toxin-host interactions. J Biol Chem (2003) 1.41
Gamma-secretase activation of notch signaling regulates the balance of proximal and distal fates in progenitor cells of the developing lung. J Biol Chem (2008) 1.40
A dumbbell-shaped small molecule that promotes cell adhesion and growth. Chem Biol (2009) 1.39
Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc (2009) 1.38
Repulsive axon guidance molecule Slit3 is a novel angiogenic factor. Blood (2009) 1.37
Retinoic acid regulates morphogenesis and patterning of posterior foregut derivatives. Dev Biol (2006) 1.37
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol (2007) 1.36
Cellular heparan sulfate participates in the metabolism of prions. J Biol Chem (2003) 1.34
Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. Biochim Biophys Acta (2002) 1.34
Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J Biol Chem (2004) 1.33
Engineering sulfotransferases to modify heparan sulfate. Nat Chem Biol (2008) 1.32
Transcriptome-based systematic identification of extracellular matrix proteins. Proc Natl Acad Sci U S A (2008) 1.31
Neuroepithelial body microenvironment is a niche for a distinct subset of Clara-like precursors in the developing airways. Proc Natl Acad Sci U S A (2012) 1.31
Identification of novel chondroitin proteoglycans in Caenorhabditis elegans: embryonic cell division depends on CPG-1 and CPG-2. J Cell Biol (2006) 1.29
Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development (2007) 1.27
Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality. J Biol Chem (2007) 1.27
Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci U S A (2011) 1.26
Surfen, a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci U S A (2008) 1.26
Retinoic acid selectively regulates Fgf10 expression and maintains cell identity in the prospective lung field of the developing foregut. Dev Biol (2004) 1.26
Differential expression of components of the microRNA machinery during mouse organogenesis. Biochem Biophys Res Commun (2005) 1.25
Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol (2003) 1.24
Distinct roles for retinoic acid receptors alpha and beta in early lung morphogenesis. Dev Biol (2006) 1.24
Molecular cloning and characterization of chondroitin polymerase from Escherichia coli strain K4. J Biol Chem (2002) 1.24
Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells (2007) 1.23
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. J Virol (2004) 1.23
Functional UDP-xylose transport across the endoplasmic reticulum/Golgi membrane in a Chinese hamster ovary cell mutant defective in UDP-xylose Synthase. J Biol Chem (2008) 1.23
Molecular heterogeneity of the SHAP-hyaluronan complex. Isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis. J Biol Chem (2003) 1.22
6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture. J Biol Chem (2008) 1.22
Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol (2007) 1.22
Regulation of Notch signaling by Drosophila heparan sulfate 3-O sulfotransferase. J Cell Biol (2004) 1.21
Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci (2008) 1.20
Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. Cancer Res (2010) 1.19
Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. J Virol (2002) 1.19